Blueprint Medicines Corporation (BPMC): Price and Financial Metrics

BPMC POWR Grades

• Growth is the dimension where BPMC ranks best; there it ranks ahead of 58.28% of US stocks.
• BPMC's strongest trending metric is Quality; it's been moving down over the last 177 days.
• BPMC's current lowest rank is in the Stability metric (where it is better than 6.56% of US stocks).

BPMC Stock Summary

• With a price/sales ratio of 20.26, BLUEPRINT MEDICINES CORP has a higher such ratio than 94.41% of stocks in our set.
• With a year-over-year growth in debt of 36.92%, BLUEPRINT MEDICINES CORP's debt growth rate surpasses 83.66% of about US stocks.
• As for revenue growth, note that BPMC's revenue has grown -20.59% over the past 12 months; that beats the revenue growth of merely 13.7% of US companies in our set.
• If you're looking for stocks that are quantitatively similar to BLUEPRINT MEDICINES CORP, a group of peers worth examining would be DCPH, FULC, ADAP, SPCE, and ADVM.
• Visit BPMC's SEC page to see the company's official filings. To visit the company's web site, go to www.blueprintmedicines.com.

BPMC Valuation Summary

• In comparison to the median Healthcare stock, BPMC's price/sales ratio is 900% higher, now standing at 18.5.
• Over the past 104 months, BPMC's EV/EBIT ratio has gone up 2.7.

Below are key valuation metrics over time for BPMC.

BPMC Growth Metrics

The 2 year price growth rate now stands at 6.53%.
• The 4 year cash and equivalents growth rate now stands at 560.04%.
• Its 2 year net income to common stockholders growth rate is now at -75.19%.

BPMC's revenue has moved up $205,764,000 over the prior 33 months.

The table below shows BPMC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	272.276	-394.986	-717.557
2022-06-30	230.487	-360.692	-701.635
2022-03-31	221.235	-305.601	-650.37
2021-12-31	180.08	-298.653	-644.085
2021-09-30	107.165	-309.338	-411.067
2021-06-30	828.095	408.584	340.152

BPMC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• BPMC has a Quality Grade of C, ranking ahead of 33.2% of graded US stocks.
• BPMC's asset turnover comes in at 0.067 -- ranking 297th of 682 Pharmaceutical Products stocks.
• OTLC, SGEN, and OCGN are the stocks whose asset turnover ratios are most correlated with BPMC.

The table below shows BPMC's key quality metrics over time.